Evidence map›Paper›PMID 32984044›Full record

ArticleFrontiers in oncology2020

Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis).

Albrecht Reichle, Daniel Heudobler, Christopher Gerner, Pan Pantziarka, Eugenio Martinelli, Ernst Holler, Francesca Corsi, Lina Ghibelli

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Albrecht ReichleDepartment of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
Daniel HeudoblerDepartment of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
Christopher GernerFaculty Chemistry, Institut for Analytical Chemistry, University Vienna, Vienna, Austria.
Pan PantziarkaThe George Pantziarka TP53 Trust, London, United Kingdom.
Eugenio MartinelliDepartment of Electronic Engineering, University of Rome Tor Vergata, Rome, Italy.
Ernst HollerDepartment of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
Francesca CorsiDepartment Biology, Universita' di Roma Tor Vergata, Rome, Italy.
Lina GhibelliDepartment Biology, Universita' di Roma Tor Vergata, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anakoinosisbiomodulatory drugschemopreventionmaster modifiers of tumor tissuesrefractory metastatic cancerreverse anakoinosistargeted tissue engineeringtissue homeostasis

Identifiers

PMID32984044
PMCPMC7492644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.